Show
Sort by
-
Completeness of reporting oligometastatic disease characteristics in literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature
-
ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium
-
- Journal Article
- A2
- open access
Neurocognitive functioning following lung cancer treatment : the PRO-Long study
-
- Miscellaneous
- open access
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 (vol 49, pg 1386, 2022)
-
What really matters for cancer care : health systems strengthening or technological innovation?
-
- Journal Article
- A1
- open access
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer
-
- Journal Article
- A1
- open access
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
-
- Journal Article
- A1
- open access
Variable and fixed costs in NHS radiotherapy : consequences for increasing hypo fractionation
-
- Journal Article
- A1
- open access
Innovation, value and reimbursement in radiation and complex surgical oncology : time to rethink
-
- Journal Article
- A2
- open access
Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk